No Data
Kura Oncology's Stock Sinks To US$8.94, But Insiders Sold Even Lower
LifeSci Capital Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $37
Jonathan Chang Recommends 'Buy' on Kura Oncology Amid Promising Ziftomenib Advancements in AML Treatment
Analysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Kura Oncology (KURA)
Express News | Cantor Fitzgerald Reiterates Overweight on Kura Oncologyto Overweight